Gemphire Therapeutics Enrolls First Patient in the COBALT-1 Trial Investigating Gemcabene in Homozygous Familial ...
Phase 2b Study to Determine Safety and Tolerability of Gemcabene in HoFH Topline Data Readout Currently Anticipated in First Half -2017 LIVONIA, Mich., Sept. 26, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (Nasdaq:GEMP), a clinical-stage …